Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Laço, Mário N ^a,b   Cortes, Luisa ^a   Travis, Sue M ^c   Paulson, Henry L ^d   Rego, A Cristina ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; GLUTATHIONE TRANSFERASE; POLYGLUTAMINE; PROTEIN P97; RECOMBINANT PROTEIN; UBIQUITINATED PROTEIN; VALOSIN CONTAINING PROTEIN;

ANIMAL CELL; ARTICLE; CYTOPLASM; ENZYME KINETICS; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MACHADO JOSEPH DISEASE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SPINOCEREBELLAR DEGENERATION; WILD TYPE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; HYDROLASES; KINETICS; MODELS, BIOLOGICAL; MUTANT PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDE HYDROLASES; PROTEIN BINDING; REPRESSOR PROTEINS; SUBSTRATE SPECIFICITY; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN;

EID: 84866103154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043563     Document Type: Article

References (64)

1. Burnett B, Li F, Pittman RN, (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet 12 (23): 3195-3205.
2. Berke SJ, Chai Y, Marrs GL, Wen H, Paulson HL, (2005) Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin3. J Biol Chem 280 (36): 32026-32034.
3. Winborn BJ, Travis SM, Todi SV, Scaglione KM, Xu P, et al. (2008) The deubiquitinating enzyme ataxin-3, a polyglutamine protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem 283 (39): 26436-26443.
4. Riess O, Rüb U, Pastore A, Bauer P, Schöls L, (2008) SCA3: Neurological features, pathogenesis and animal models. Cerebellum 7: 125-137.
5. Paulson HL, (2007) Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3. Semin Neurol 27 (2): 133-142.
6. Bauer PO, Nukina N, (2009) The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J Neurochem 110 (6): 1737-1765.
7. Hands SL, Wyttenbach A, (2010) Neurotoxic protein oligomerisation associated with polyglutamine diseases. Acta Neuropathol 120: 419-437.
8. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, et al. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebelar ataxia type 3. Neuron 19 (2): 333-344.
9. Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, et al. (1996) Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuroathological features. Ann Neurol 39 (4): 490-499.
10. Bevinino AE, Loll PJ, (2001) An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta-fibrils. Proc Natl Acad Sci USA 98 (21): 11955-11960.
11. Ellisdon AM, Pearce MC, Bottomley SP, (2007) Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J Mol Biol 368 (2): 595-605.
12. Paulson HL, Das SS, Crino PB, Perrez MK, Patel SC, et al. (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 41 (4): 453-462.
13. Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, et al. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 143 (6): 1457-1470.
14. Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, et al. (2006) Proteolytic cleavage of polyglutamine-expanded ataxin-3 is crucial for aggregation and sequestration of non-expanded ataxin-3. Hum Mol Genet 15 (4): 555-568.
15. Gales L, Cortes L, Almeida C, Melo CV, do Carmo Costa M, et al. (2005) Towards a structural understannding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. J Mol Biol 353 (3): 642-654.
16. Ellisdon AM, Thomas B, Bottomley SP, (2006) The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J Biol Chem 281 (25): 16888-16896.
17. Nozaki K, Onodera O, Takano H, Tsuji S, (2001) Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation. Neuroreport 12 (15): 3357-3364.
18. Saunders HM, Bottomley SP, (2009) Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins. Protein Eng Des Sel 22 (8): 447-451.
19. Fei E, Jia N, Zhang T, Ma X, Wang H, et al. (2007) Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3. Biochem Biophys Res Commun 357 (2): 487-492.
20. Bichelmeier U, Schmidt T, Hubener J, Boy J, Ruttiger L, et al. (2007) Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci 27 (28): 7418-7428.
21. Todi SV, Winborn BJ, Scaglione KM, Blount JR, Travis SM, et al. (2009) Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J 28 (4): 372-382.
22. Macedo-Ribeiro S, Cortes L, Maciel P, Carvalho AL, (2009) Nucleocytoplasmic shuttling activity of ataxin-3. PLoS One 4 (6): e5834.
23. Mueller T, Breuer P, Schmitt I, Walter J, Evert BO, et al. (2009) CK2-dependent phosporylation determines cellular localization and stability of ataxin-3. Hum Mol Genet 18 (17): 3334-3343.
24. Schmitt I, Linden M, Khazneh H, Evert BO, Breuer P, et al. (2007) Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem Biophys Res Commun 362 (3): 734-739.
25. Zhong X, Pittman RN, (2006) Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum Mol Genet 15 (16): 2409-2420.
26. Reina CP, Zhong X, Pittman RN, (2010) Proteotoxic stress increases nuclear localization of ataxin-3. Hum Mol Genet 19 (2): 235-249.
27. Wang G, Sawai N, Kotliarova S, Kanazawa I, Nukina N, (2000) Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, hHR23A and hHR23B. Hum Mol Genet 9 (12): 1795-1803.
28. Boeddrich A, Gaumer S, Haacke A, Tzvetkov N, Albrecht M, et al. (2006) An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J 25 (7): 1547-1558.
29. Evert BO, Araujo J, Vieira-Saecker AM, de Vos RA, Harendza S, et al. (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J Neurosci 26 (44): 11474-11486.
30. Mazzucchelli S, De Palma A, Riva M, D'Urzo A, Pozzi C, et al. (2009) Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin. Int J Biochem Cell Biol 41 (12): 2485-2492.
31. Dantuma NP, Heinen C, Hoogstraten D, (2009) The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation. DNA repair (Amst) 8 (4): 449-460.
32. Raasi S, Orlov I, Fleming KG, Pickart CM, (2004) Binding of polyubiquitin chains to ubiquitin-associated (UBA) domains of hHR23A. J Mol Biol 341 (5): 1367-1379.
33. Madsen L, Seeger M, Semple CA, Hartmann-Petersen R, (2009) New ATPase regulators- p97 goes to the PUB. Int J Biochem Cell Biol 41 (12): 2380-2388.
34. Todi SV, Laco MN, Winborn BL, Travis SM, Wem HM, et al. (2007) Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity. J Biol Chem 282 (40): 29348-29358.
35. Chen L, Madura K, (2006) Evidence for distinct functions for hman DNA repair factors hHR23A and hHR23B. FEBS Lett 580 (14): 3401-3408.
36. Trottier Y, Cancel G, An-Gourfinkel I, Lutz Y, Weber C, et al. (1998) Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol Dis 5 (5): 335-347.
37. Antony PM, Mämtele S, Mollenkopf P, Boy J, Kehlenbach RH, et al. (2009) Identification and functional dissection of localization signals within ataxin-3. Neurobiol Dis 36 (2): 280-292.
38. Nicastro G, Menon RP, Masino L, Knowles PP, McDonald NQ, et al. (2005) The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc Natl Acad Sci USA 102 (30): 10493-10498.
39. Nicastro G, Todi SV, Karaca E, Bonvin AM, Paulson HL, et al. (2010) Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3. PloS One 5 (8): e12430.
40. Rodrigues AJ, Neves-Carvalho A, Ferro A, Rokka A, Corthals G, et al. (2009) ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in Caenorhabditis elegans. Biochem Biophys Res Commun 386 (4): 575-581.
41. Dalal S, Hanson PI, (2001) Membrane traffic: what drives the AAA motor? Cell 104: 5-8.
42. Mori-Konya C, Kato N, Maeda R, Yasuda K, Higashimae N, et al. (2009) p97/valosin-containing protein (VCP/p97) is highly modulated by phosphorylation and acetylation. Genes Cells 14 (4): 483-497.
43. Doss-Pepe EW, Stenroos ES, Johnson WG, Madura K, (2003) Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol 23 (18): 6469-6483.
44. Yao T, Song L, Xu W, DeMartino GN, Florens L, et al. (2006) Proteasome recruitment and activation of the Ucn37 deubiquitinating enzyme by Adrm1. Nat Cell Biol 8 (9): 994-1002.
45. Cohn MA, Kowal P, Yang K, Haas W, Huang TT, et al. (2007) A UAF1-containing multisubunit complex regulates the Faconi anemia pathway. Mol Cell 28 (5): 786-797.
46. Kuhlbrodt K, Janiesch PC, Kevei É, Segref A, Barikbin R, et al. (2011) The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis. Nat Cell Biol 13 (3): 273-281.
47. Beuron F, Dreveny I, Yuan X, Pye VE, McKeown C, et al. (2006) Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J 25 (9): 1967-1976.
48. Tait D, Riccio M, Sittler A, Scerzinger E, Santi S, et al. (1998) Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum Mol Genet 7 (6): 991-997.
49. Pozzi C, Valtorta M, Tedeschi G, Galbusera E, Pastori V, et al. (2008) Study of subcellular localization and proteolysis of ataxin-3. Neurobiol Dis 30 (2): 190-200.
50. Chai Y, Shao J, Miller VM, Williams A, Paulson HL, (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci USA 99 (14): 9310-9315.
51. Rockel TD, Stuhlmann D, von Mikecz A, (2005) Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J Cell Sci 118 (22): 5231-5242.
52. Scharf A, Rockel TD, von Mikecz A, (2007) Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry. Histochem Cell Biol 127 (6): 591-601.
53. Kang Y, Chen X, Lary JW, Cole JL, Walters KJ, (2007) Defining how ubiquitin receptors hHR23A and S5a bind polyubiquitin. J Mol Biol 369 (1): 168-76.
54. Hsieh HC, Hsieh YH, Huang YH, Shen FC, Tsai FC, et al. (2005) HHR23A, a human homolog of Saccharomyces cerevisiae Rad23, regulates xeroderma pigmentosum C protein and is required for nucleotide excision repair. Biochem Biophys Res Commun 335 (19): 181-187.
55. Evert BO, Vogt IR, Vieira-Saecker AM, Ozimek L, de Vos RA, et al. (2003) Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J Neuropathol Exp Neurol 62 (10): 1006-1018.
56. Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, et al. (2001) Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci 21 (15): 5389-5396.
57. Ferro A, Carvalho AL, Teixeira-Castro A, Almeida C, Tomé RJ, et al. (2007) NEDD8: a new ataxin-3 interactor. Biochem Biophys Acta 1773 (11): 1619-1627.
58. Tao RS, Fei EK, Ying Z, Wang HF, Wang GH, (2008) Casein kinase 2 interacts with and phosporylates ataxin-3. Neurosci Bull 24 (5): 271-7.
59. Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, et al. (2011) The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet 20 (1): 141-154.
60. Takeshita Y, Fujinaga R, Kokubu K, Islam MN, Jahan MR, et al. (2011) Interaction of ataxin-3 with huntingtin-associated protein 1 through Josephin domain. Neuroreport 22 (5): 232-238.
61. Wang Q, Li L, Ye Y, (2008) Inhibition of p97-dependent protein degradation by Eeyarestatin I. J Biol Chem 283 (12): 7445-7454.
62. Varadan R, Assfalg M, Raasi S, Pickart C, Fushman D, (2005) Structural determinants for selective recognition of a Lys48-linked polyubiquitin chain by a UBA domain. Mol Cell 18 (6): 687-698.
63. Venkatraman P, Wetzel R, Tanaka M, Nukina N, Goldberg AL, (2004) Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell 14 (1): 95-104.
64. Díaz-Hernández M, Valera AG, Morán MA, Gómez-Ramos P, Alvarez-Castelao B, et al. (2006) Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. J Neurochem 9: 1585-1596.